4CPS-186 Effectiveness and safety of cilgavimab/tixagevimab in pre-exposure prophylaxis of COVID-19 | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 4: Clinical pharmacy services

4CPS-186 Effectiveness and safety of cilgavimab/tixagevimab in pre-exposure prophylaxis of COVID-19

Free

Online download statistics by month:

Online download statistics by month: March 2023 to November 2024

	Abstract	Full	Pdf
Mar 2023	20	0	2
Apr 2023	96	0	11
May 2023	38	0	4
Jun 2023	20	0	3
Jul 2023	29	0	6
Aug 2023	22	0	1
Sep 2023	14	0	4
Oct 2023	8	0	2
Nov 2023	27	0	5
Dec 2023	24	0	6
Jan 2024	5	0	0
Feb 2024	16	0	1
Mar 2024	37	0	12
Apr 2024	14	0	5
May 2024	14	0	0
Jun 2024	7	0	1
Jul 2024	6	0	1
Aug 2024	11	0	2
Sep 2024	13	0	2
Oct 2024	18	0	3
Nov 2024	14	0	3
Total	453	0	74